Medical Oncologist
Managing Enhertu side effects
Blood Counts, Hair Loss and — Heart Monitoring on Enhertu
Low blood counts, hair loss and heart monitoring are expected parts of treatment with Enhertu. Most are manageable at home, but a few signs mean calling your team the same day — or going straight to hospital.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Blood counts are checked every cycle — Enhertu can lower your white cells, red cells and platelets. Your team reviews these before every infusion to decide whether it is safe to proceed.
- Hair loss is common and expected — Hair thinning or loss affects many people on Enhertu. It is distressing but it is not a sign that something is going wrong with your treatment.
- Your heart is monitored routinely — ECHO scans are arranged before treatment begins and at regular intervals during it. Most changes are caught early and can be managed.
- Fever always needs same-day contact — When white blood cells are low, fever is a potential medical emergency — not a symptom to watch at home overnight.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Low blood counts, hair loss and heart changes are all expected side effects of Enhertu, and your team monitors for them at every cycle. Most are manageable. Fever when your counts are low is the exception — that needs same-day emergency care. NCCN and ASCO guidance treats any fever during low white-count periods as urgent.
How do you tell ordinary tiredness from something that needs action?
| Sign | Monitor at home | Call your team today | Go now |
|---|---|---|---|
| Fatigue | Mild, improves with rest between cycles | Severe enough to stop daily tasks, or not improving between cycles | With fever, chest pain, or new breathlessness |
| Fever or chills | — | Any fever or sudden chills — do not wait to see if it passes | Fever with confusion, rapid breathing, or collapse |
| Bruising or bleeding | Minor bruising from small knocks | Heavier or more prolonged bleeding than feels normal for you | Bleeding that will not stop with firm pressure |
| Breathlessness | Mild on steep stairs, unchanged from before treatment | Any new or worsening breathlessness since starting Enhertu | Sudden or severe breathlessness at any activity level |
| Hair loss | Thinning or shedding from early in treatment — expected and non-urgent | Scalp that becomes sore, blistered, or develops open sores | — |
| Typically starts | Hair loss and fatigue typically appear from early in treatment. Blood count dips tend to follow each infusion. | Report any new symptom promptly — do not wait for your next scheduled visit. | — |
What can you do at home during low-count periods?
The three most useful things to have in place are a working thermometer, the fever threshold your oncology team has given you, and a clear sense of your usual symptom pattern so you notice when something changes.
The days after each infusion are when white cells are most likely to be at their lowest. Avoiding close contact with people who are unwell during this window is sensible — you do not need to isolate, but crowded indoor spaces carry more risk than usual.
Fatigue during low-count periods is partly driven by a fall in red blood cells. Rest without guilt. If fatigue is stopping you from eating, drinking, or moving around, tell your team — that level of impact is worth reporting.
Hair loss does not need medical management, but scalp care matters. Tell your team if your scalp becomes sore or develops open sores, and ask about scalp cooling before you start if it is available at your centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Not sure whether this counts as an emergency?
Call the helpline. It is always better to check than to wait.
Before and during treatment — things to have in place
- Keep a working thermometer at home from your first cycle.
- Write down the fever threshold your oncologist has told you to act on.
- Attend every blood draw before your infusion — these decide whether it is safe to proceed.
- Attend all scheduled ECHO appointments. Missing one can delay your next treatment cycle.
- Tell your dentist and any other treating doctor that you are on Enhertu before any procedure.
- Check with your oncology team before taking any painkiller, including aspirin or ibuprofen.
- Ask about scalp cooling or head coverings before hair loss begins if you want to prepare.
Did you know?
Enhertu is an antibody-drug conjugate — it uses a HER2-targeting antibody to deliver a chemotherapy payload directly into cancer cells. This precision is what distinguishes it from standard chemotherapy.
The same mechanism explains why blood counts and hair are still affected: the chemotherapy payload reaches some healthy fast-dividing cells as well. Your blood counts are checked before every cycle because your team will hold or adjust treatment if the numbers are not safe to proceed.
Source: NCCN Clinical Practice Guidelines: Hematopoietic Growth Factors; ASCO Clinical Practice Guideline on Management of Immunotherapy-Related and Targeted Therapy Toxicities
Questions people ask most about these side effects
Why does Enhertu need to monitor the heart at all?
Enhertu targets HER2, a protein found on the surface of some cancer cells. HER2 also plays a role in maintaining normal heart muscle function, which is why drugs that target it can occasionally cause a change in how efficiently the heart pumps. This is measured by an ECHO scan as the ejection fraction — the proportion of blood the heart pushes out with each beat. NCCN and ASCO both require baseline and interval ECHO monitoring for all patients on HER2-directed therapy, including Enhertu. Most people see no meaningful change. When a change is found early through routine monitoring, treatment can be paused or adjusted before it becomes a more serious problem.
Will my hair grow back after Enhertu?
For most people, yes. Hair loss on Enhertu is caused by the chemotherapy component of the drug, and like chemotherapy-related hair loss generally, it is usually reversible after treatment ends. Regrowth varies from person to person and can take several months after your last dose. Some people find the returning hair is temporarily a slightly different texture. Scalp cooling during infusions can reduce the degree of loss for some people — ask your team whether it is available and suitable for you before you start, not after loss has already begun, as that is when it is most likely to help.
What happens if my ECHO scan shows a change in heart function?
The response depends on how significant the change is and whether you have any symptoms. A mild reduction with no symptoms is often managed by pausing treatment temporarily and repeating the scan after a few weeks. Many people are able to restart Enhertu once the measurement recovers. A larger change, or symptoms such as new breathlessness or ankle swelling, may lead to a longer pause and involvement of a cardiologist. NCCN and ASCO guidance sets out a structured approach to this decision. The goal is to protect your heart while keeping your cancer treatment on track, and routine monitoring gives your team the information to do both.
Can I exercise when my blood counts are low?
Gentle movement is generally not harmful, and light walking is almost always fine and can actively help with fatigue and mood. The exception is when platelet counts are very low, in which case your team may ask you to avoid activities with a risk of falls or injury. Ask your oncologist what is appropriate during the low-count window each cycle rather than assuming you must rest completely or that normal activity is safe. Your team will know from your blood results which period carries the most caution, and the answer may differ from cycle to cycle depending on how your counts are responding.
Is it safe to be around my family, including young children, when my counts are low?
Yes, in most situations. The risk runs in one direction: you catching something from others, not the treatment passing to them. Enhertu is not contagious. Children who are up to date with their vaccinations are generally lower risk than adults with an active respiratory or gastrointestinal infection. During the low-count days after each infusion, ask anyone in your household who is unwell to keep some distance where possible. Your team can tell you which part of each cycle is the most vulnerable window so you can plan around it rather than restricting contact throughout the entire treatment period.
Explore 75 more Breast Cancer Targeted Medicines topics
Drug Deep Dive: Trastuzumab Deruxtecan (Enhertu)
- Diet and Nutrition While on Trastuzumab Deruxtecan
- Drug, Food and Supplement Interactions With Trastuzumab Deruxtecan
- Enhertu Myths: 'It's Just Stronger Herceptin' and Cost Misconceptions
- Enhertu in Breast, Gastric and Lung Cancer: One Drug, Three Diseases
- Fertility, Pregnancy and Contraception on Trastuzumab Deruxtecan
- HER2-Low Breast Cancer: How Enhertu Created an Entirely New Patient Group
- How Does Trastuzumab Deruxtecan Work? The HER2-Directed Antibody-Drug Conjugate Explained
- How Long Does Trastuzumab Deruxtecan Take to Work?
- How Long Will You Stay on Trastuzumab Deruxtecan?
- Interstitial Lung Disease on Enhertu: The Side Effect That Needs Immediate Action
- Low Blood Counts, Hair Loss and Heart Monitoring on Enhertu
- Nausea and Vomiting on Trastuzumab Deruxtecan: Managing a High-Risk ADC
- Tests and Monitoring While You Are on Trastuzumab Deruxtecan
- Trastuzumab Deruxtecan (Enhertu): The Complete Patient Guide
- Trastuzumab Deruxtecan Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Deruxtecan Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Deruxtecan Side Effects: The Complete List and Timeline
- Trastuzumab Deruxtecan Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab Deruxtecan in Elderly Patients and Those With Other Illnesses
- Trastuzumab Deruxtecan vs T-DM1 and Trastuzumab: How ADCs Differ
- When Trastuzumab Deruxtecan Stops Working: Resistance and What Comes Next
- Where Trastuzumab Deruxtecan Fits Alongside Chemotherapy and Hormone Therapy
- Who Is Eligible for Trastuzumab Deruxtecan? HER2-Positive and HER2-Low Breast, Gastric and Lung Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab Deruxtecan?
- Work, Travel and Daily Life on Trastuzumab Deruxtecan
Drug Deep Dive: Palbociclib (Ibrance)
- Diet and Nutrition While on Palbociclib
- Drug, Food and Supplement Interactions With Palbociclib
- Fatigue on Palbociclib: Why It Happens and What Genuinely Helps
- Fertility, Pregnancy and Contraception on Palbociclib
- How Does Palbociclib Work? The CDK4/6 Inhibitor Explained
- How Long Does Palbociclib Take to Work?
- How Long Will You Stay on Palbociclib?
- Low White Cell Count on Palbociclib: Expected, and Rarely Dangerous
- Mouth Sores and Infection Risk on Palbociclib
- Palbociclib (Ibrance, Palbace): The Complete Patient Guide
- Palbociclib Myths: Low Counts, Hair Loss and Stopping Early
- Palbociclib Price in India: Brand, Generic and Monthly Cost
- Palbociclib Side Effects: The Complete List and Timeline
- Palbociclib Success Rate and Survival: An Honest Look at the Numbers
- Palbociclib With Letrozole or Fulvestrant: Understanding Your Combination
- Palbociclib in Early Breast Cancer: Why It Is Not Given After Surgery
- Palbociclib in Elderly Patients and Those With Other Illnesses
- Palbociclib vs Ribociclib vs Abemaciclib: Which CDK4/6 Inhibitor?
- Taking Palbociclib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Palbociclib
- The 21-Days-On, 7-Days-Off Palbociclib Cycle Explained
- When Palbociclib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Palbociclib? Hormone-Receptor-Positive, HER2-Negative Breast Cancer
- Will Insurance or a Government Scheme Pay for Palbociclib?
- Work, Travel and Daily Life on Palbociclib
Drug Deep Dive: Trastuzumab (Herceptin)
- Adjuvant Trastuzumab: Why Exactly 12 Months After Surgery?
- Diet and Nutrition While on Trastuzumab
- Drug, Food and Supplement Interactions With Trastuzumab
- Fatigue, Chills and Flu-Like Symptoms After a Trastuzumab Infusion
- Fertility, Pregnancy and Contraception on Trastuzumab
- Heart Function and Trastuzumab: Understanding Your ECHO Reports
- Herceptin vs Biosimilar Trastuzumab: Are They Really the Same?
- How Does Trastuzumab Work? The Anti-HER2 Monoclonal Antibody Explained
- How Long Does Trastuzumab Take to Work?
- How Long Will You Stay on Trastuzumab?
- Subcutaneous Trastuzumab vs IV Infusion: Which Suits You Better?
- Tests and Monitoring While You Are on Trastuzumab
- Trastuzumab (Herceptin and biosimilars): The Complete Patient Guide
- Trastuzumab Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Infusion Reactions: What Happens and How They're Managed
- Trastuzumab Myths: 'It's Chemotherapy' and Other Misunderstandings
- Trastuzumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Side Effects: The Complete List and Timeline
- Trastuzumab Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab With Pertuzumab, Chemotherapy and Hormone Therapy
- Trastuzumab in Elderly Patients and Those With Other Illnesses
- When Trastuzumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Trastuzumab? HER2-Positive Breast and Gastric Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab?
- Work, Travel and Daily Life on Trastuzumab
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
What temperature counts as a fever when I am on Enhertu?
The specific threshold should be given to you by your oncology team, because it can vary between centres and individual circumstances. If no one has told you a number, ask at your very next appointment — you should not have to guess this. What NCCN and ASCO guidance is clear on is that any fever during a period of low white blood cell counts is a potential emergency, not a symptom to monitor overnight at home. When uncertain, call your team and give them your temperature reading rather than deciding what to do on your own.
Can I take medicine to boost my blood counts?
Your oncology team may prescribe growth factor injections to support your white blood cell count if it falls to a level that concerns them — this is a clinical decision, and you should not seek these independently. For low red blood cells, treatment depends on how low the count is and how it is affecting you day to day. Do not take iron supplements or any over-the-counter remedy without first asking your oncologist, as some interact with cancer treatment or can obscure what the blood results are actually showing.
How long does fatigue from low blood counts last?
Fatigue from low counts tends to follow the infusion cycle rather than build steadily over time. The lowest point usually falls in the days immediately after each dose, then improves before the next cycle. If fatigue is not recovering between cycles, or is getting worse with each one, tell your team — that pattern matters and may lead to a closer look at your counts or an adjustment to the treatment plan. Fatigue that stops you eating or drinking is always worth reporting, regardless of where you are in the cycle.
Does hair loss from Enhertu happen all at once?
Usually not. Shedding tends to begin gradually from early in treatment and progresses over time. The degree varies between people — some experience significant loss, others moderate thinning. Preparing before loss begins is easier: cutting hair shorter, asking about scalp cooling, or arranging a wig or head coverings can all be done in advance. Tell your team if your scalp becomes painful or develops sores — that is a different issue from ordinary hair loss and worth assessing separately.
My ECHO scan was normal but I still feel short of breath. What should I do?
Tell your oncology team the same day rather than waiting for your next appointment. A normal ECHO rules out a significant change in how well the heart is pumping, but it does not explain all breathlessness on Enhertu. Interstitial lung disease is a separate and important side effect of this drug — one that affects the lungs rather than the heart, and that an ECHO will not detect. NCCN and ASCO guidance treats any new breathlessness on Enhertu as needing prompt assessment regardless of the most recent heart scan result. Do not reassure yourself on the basis of the ECHO alone.